Mirae Asset Global Investments Co. Ltd. cut its stake in Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 9.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,766 shares of the health services provider’s stock after selling 12,571 shares during the period. Mirae Asset Global Investments Co. Ltd. owned 0.08% of Teladoc Health worth $8,782,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Wade G W & Inc. acquired a new stake in Teladoc Health in the first quarter valued at $224,000. Western Wealth Management LLC bought a new stake in Teladoc Health during the first quarter valued at $216,000. Shell Asset Management Co. increased its stake in Teladoc Health by 3.5% during the first quarter. Shell Asset Management Co. now owns 12,418 shares of the health services provider’s stock valued at $896,000 after purchasing an additional 423 shares during the last quarter. LGT Group Foundation increased its stake in Teladoc Health by 151.4% during the first quarter. LGT Group Foundation now owns 28,534 shares of the health services provider’s stock valued at $2,106,000 after purchasing an additional 17,184 shares during the last quarter. Finally, Lincoln National Corp increased its stake in Teladoc Health by 42.7% during the first quarter. Lincoln National Corp now owns 3,955 shares of the health services provider’s stock valued at $285,000 after purchasing an additional 1,184 shares during the last quarter. 92.46% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several analysts have weighed in on the stock. Stifel Nicolaus lowered their target price on shares of Teladoc Health from $36.00 to $30.00 in a research note on Thursday, July 28th. Citigroup lowered their price target on shares of Teladoc Health from $43.00 to $38.00 in a research report on Thursday, July 28th. The Goldman Sachs Group lowered shares of Teladoc Health from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $55.00 to $36.00 in a research report on Thursday, July 28th. Cowen lowered shares of Teladoc Health from an “outperform” rating to a “market perform” rating and lowered their price target for the stock from $58.00 to $34.00 in a research report on Tuesday, August 2nd. Finally, Canaccord Genuity Group lowered their price target on shares of Teladoc Health from $50.00 to $45.00 in a research report on Thursday, July 28th. Two research analysts have rated the stock with a sell rating, twenty-four have assigned a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Teladoc Health currently has a consensus rating of “Hold” and an average target price of $66.88.
Insider Buying and Selling at Teladoc Health
Teladoc Health Price Performance
TDOC stock opened at $29.45 on Wednesday. The company has a current ratio of 3.38, a quick ratio of 3.22 and a debt-to-equity ratio of 0.25. Teladoc Health, Inc. has a one year low of $27.38 and a one year high of $156.82. The firm has a market capitalization of $4.75 billion, a PE ratio of -0.48 and a beta of 0.86. The firm has a 50-day moving average of $35.67 and a two-hundred day moving average of $43.13.
Teladoc Health (NYSE:TDOC – Get Rating) last posted its quarterly earnings data on Wednesday, July 27th. The health services provider reported ($0.44) EPS for the quarter, beating analysts’ consensus estimates of ($0.71) by $0.27. Teladoc Health had a negative net margin of 441.94% and a negative return on equity of 2.04%. The company had revenue of $592.38 million during the quarter, compared to analyst estimates of $586.86 million. On average, analysts forecast that Teladoc Health, Inc. will post -1.54 earnings per share for the current year.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- 3 Airline Stocks Stuck in a Holding Pattern
- Roku Stock is Down but Not Out
- If You’re Hungry for Value, Take a Bite on Ruth’s Hospitality Grp
- Is Ford Rolling To A Rebound After Its Q3 Warning
- Has AMD stock stock fallen too far?
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.